bioAffinity Technologies Inc — Quarterly Cash Flow (NASDAQ:BIAF) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics

Quarterly Annual

Total assets 6.55 M6.51 M5.55 M4.75 M11.55 M Total liabilities 3.43 M3.91 M4.11 M6.89 M2.64 M Total equity 3.12 M2.6 M1.44 M-2.14 M8.9 M Total liabilities & shareholders' equities 6.55 M6.51 M5.55 M4.75 M11.55 M Total debt 281.68 K—260 B305.95 K171.16 K Net debt -518.32 K—260 B-494.05 K-7.53 M

新闻

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25%

美国股市收低；截至收盘道琼斯工业平均指数下跌0.25%

bioAffinity Technologies公布2025年财务业绩

bioAffinity Technologies reports 2025 financial results

bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth - bioAffinity Technologies (NASDAQ:BIAF)

BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?

bioAffinity在AAAAI会议上展示哮喘疗法匹配研究

bioAffinity presents asthma therapy matching research at AAAAI

bioAffinity启动肺癌诊断测试研究

bioAffinity launches study to test lung cancer diagnostic

CyPath Lung检测帮助老年患者避免不必要的活检

CyPath Lung test helps avoid unnecessary biopsy in elderly patient